Highlights Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:35:55 16/01/2026 GMT			5-day change	1st Jan Change
41.52 ^EUR	-1.38%		+6.78%	+12.17%

01-16	Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup	DJ
01-16	Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation	RE

Highlights

01-16	Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup	DJ
01-16	Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation	RE
01-16	Bayer AG - Company expects a decision on merits during court's 2026 session, which ends in June	RE
01-16	Bayer AG - U.S. Supreme Court today announced that it will review Durnell Roundup case	RE
01-16	US Supreme Court to hear Bayer's bid to curb Roundup cases	RE
01-16	U.S. Supreme Court agrees to hear Bayer's bid to limit lawsuits filed under state laws over its weedkiller Roundup	RE
01-16	Bayer's Eylea Secures EU Approval for Retinal Vein Occlusion	MT
01-16	Dax Expected to Open Lower – Inflation and Auto Sector in Focus	RE
01-14	Orion Estimates to Hit Annual Net Sales Target for Nubeqa by Decade-end	MT
01-14	Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug	DJ
01-14	Bayer Continues Recovery Rally – Sees Major Pharma Potential Ahead	DP
01-14	Bayer Sees Pharmaceutical Business on Growth Trajectory	DP
01-14	Historic Morning Record for the CAC 40
01-14	Bayer Targets Around 30 Percent Margin for Pharma Division by 2030	RE
01-13	Bayer targets return to mid-single-digit pharma growth by 2027	RE
01-12	Bayer acquires two imaging markers currently in development from Attralus, Inc	RE
01-10	FluroTech Ltd. Announces Chief Financial Officer Changes	CI
01-08	Askbio Inc. Announces Fda Acceptance of Investigational New Drug Application for Ab-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease	CI
01-08	Bayer Shares Climb Further on EU Seed Policy Report	DP
01-08	FDA accepts AskBio investigational new drug for late-onset Pompe disease	RE
01-08	Bayer Partners with Soufflé Therapeutics to Develop siRNA Therapy for Rare Heart Disease	MT
01-08	Bayer and Souffle Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy	CI
01-08	Bayer and Souffle Therapeutics partner up to advance cell-specific heart-targeted siRNA therapy	RE
01-07	Bayer Unit Sues Pfizer, BioNTech, Moderna for Technology Misuse in COVID-19 Vaccine Production	MT
01-07	Bayer and Cradle Enter Collaboration to Enhance AI-Enabled Antibody Discovery and Optimization	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Bayer slows after strong recovery, valuation stretched

December 17, 2025 at 08:41 am

Bayer, close to the final round(up)?

June 05, 2025 at 03:56 pm

Roundup: Bayer ordered to pay $2.1bn to an American suffering from cancer

March 24, 2025 at 10:21 am